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Abstract
Summary Remaining lifetime and absolute 10-year proba-
bilities for osteoporotic fractures were determined by
gender, age, and BMD values. Remaining lifetime proba-
bility at age 50 years was 20.2% in men and 51.3% in
women and increased with advancing age and decreasing
BMD. The study validates the elements required to
populate a Swiss-specific FRAX® model.
Introduction Switzerland belongs to high-risk countries for
osteoporosis. Based on demographic projections, burden
will still increase. We assessed remaining lifetime and
absolute 10-year probabilities for osteoporotic fractures by
gender, age and BMD in order to populate FRAX®
algorithm for Switzerland.
Methods Osteoporotic fracture incidence was determined
from national epidemiological data for hospitalised frac-
tured patients from the Swiss Federal Office of Statistics
in 2000 and results of a prospective Swiss cohort with
almost 5,000 fractured patients in 2006. Validated BMD-
associated fracture risk was used together with national
death incidence and risk tables to determine remaining
lifetime and absolute 10-year fracture probabilities for hip
and major osteoporotic (hip, spine, distal radius, proximal
humerus) fractures.
Results Major osteoporotic fractures incidence was 773 and
2,078 per 100,000 men and women aged 50 and older.
Corresponding remaining lifetime probabilities at age 50
were 20.2% and 51.3%. Hospitalisation for clinical spine,
distal radius, and proximal humerus fractures reached 25%,
30% and 50%, respectively. Absolute 10-year probability of
osteoporotic fracture increased with advancing age and
decreasing BMD and was higher in women than in men.
Conclusion This study validates the elements required to
populate a Swiss-specific FRAX® model, a country at
highest risk for osteoporotic fractures.
Keywords Absolute 10-year fracture probability . FRAX® .
Hospitalisation rate . Incidence . Osteoporotic fractures .
Remaining lifetime probability
Introduction
The World Health Organization (WHO) defined osteoporo-
sis as “a systemic skeletal disease characterised by low
bone mass and microarchitectural deterioration of bone
tissue, with a consequent increase in bone fragility and
susceptibility to fracture” [1]. The most frequent complica-
tions of the disease are the “typical” osteoporotic fractures
occurring at the hip, spine, distal forearm and proximal
humerus. Furthermore, the WHO proposed an operational
definition of osteoporosis as a bone mineral density (BMD)
that lies 2.5 standard deviations or more below the average
mean value of young healthy women (T score≤−2.5 SD)
[1, 2]. Until recently and based on the latter definition,
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fracture risk was commonly expressed as the relative risk of
sustaining an osteoporotic fracture compared to the gender-
matched risk of the general population [3]. In the presence
of osteoporosis, the relative risk of osteoporotic fracture at
any age was shown to decrease with advancing age, albeit
that the absolute risk was continuously increasing, which
led to the conclusion that, for clinical use, absolute risks
may be preferred to relative risks [3]. Since then, the
determination of 10-year probability of fracture has
increasingly gained acceptance [4–11]. Gender, age, and
BMD belong to the strongest predictors of osteoporotic
fracture risk, and their combination with other clinical risk
factors has been shown to improve the specificity and
sensitivity of fracture risk prediction at the individual
patient level [12]. Recently, a fracture risk assessment tool
(FRAX®) supported by the WHO [13] was developed
based on the use of clinical risk factors with or without
BMD for several countries, including the UK [4], US [14]
and Japan [11].
One of the key requirements for the development of
FRAX® is the availability of country specific fracture
outcome and mortality data. Although the epidemiology of
hospitalised osteoporotic and non-osteoporotic fractures in
Switzerland in year 2000 was previously published [15],
the absolute 10-year and the remaining lifetime fracture
probabilities for an osteoporosis-related fracture are not
known.
The aim of the present study was to determine the
absolute 10-year and remaining lifetime fracture probabilities
by gender, age and BMD categories for the Swiss population
for future FRAX® modelling.
Methods
The incidence of hospitalisation for fractures and osteoporotic
fractures by gender, age group, and fracture type in year 2000
have been previously published based on the administrative
and medical and population structure statistics of the Swiss
Federal Office of Statistics (SFOS) [15]. For the present
analysis, the incidence by gender and 5-year age groups
starting at age 50 were used for the following osteoporosis-
related fracture sites: hip (ICD-10 codes S72.0 (fracture of
the femoral neck), S72.1 (pertrochanteric fracture) and S72.2
(subtrochanteric fracture)); spine (S22.0 (fracture of the
thoracic spine), S22.1 (multiple fractures of the thoracic
spine), S32.0 (fracture of the lumbar spine), S32.7 (multiple
fractures of the lumbar spine) and S32.8 (other fractures of
the lumbar spine)); distal radius (S52.5 (fracture of the distal
radius) and S52.6 (combined fracture of the distal radius/
ulna)); and proximal humerus (S42.2, fracture of the proximal
humerus). These previously published data represented only
hospitalised clinical fractures.
In order to determine the total number of fractures
(hospitalised and non-hospitalised) at these osteoporosis-
related sites, additional data from the Swiss OsteoCare
survey were used [16]. Briefly, the OsteoCare nationwide
survey aimed at assessing the quality level of osteoporosis
management in patients aged 50 years or older presenting
with a clinical fracture at the emergency ward of the
participating hospitals in Switzerland. In total, 4,966
consecutive men (N=1,368, mean age 69.0 years) and
women (N=3,598, mean age 73.9 years) with any clinical
fracture were recruited in eight centres between 2004 and
2006 during a mean duration of observation of 12.2 months.
For each patient, a predefined standardised questionnaire
was used in all centres to characterise the current acute
clinical fracture event. Of all hospitalised and non-
hospitalised fractures reported, those categorised as hip
(pertrochanteric and femoral neck), spine (lumbar or
thoracic), distal forearm and proximal humerus fractures
were used for the present analysis. Two hundred ninety-five
and 881 hip fractures were reported in the survey for men
and women, respectively. On the other hand, 2,506 and
8,074 hip fractures were reported as hospitalised in the
medical database of the SFOS. Therefore, the ratio between
the number of hip fractures in the OsteoCare cohort and the
number of hospitalised fractures published earlier was 8.49
(2,506/295) in men and 9.16 (8,074/881) in women.
Assuming that all hip fractures of the OsteoCare cohort
were hospitalised, this ratio was applied as a gender-
specific multiplier to the number of spine, distal radius and
proximal humerus fractures by 5-year age groups in the
OsteoCare cohort to determine the expected total (hospitalised
and non-hospitalised) number of fractures and their
corresponding incidence by gender and 5-year age group,
i.e. the expected number of fractures which would have
occurred at each predefined site if all fractures (hospitalised
and non-hospitalised) had been registered in the previously
published cohort. Furthermore, the ratio between the
number of hospitalised spine, distal radius and proximal
humerus fractures reported by the SFOS and the expected
number of these fractures resulting from extrapolation of
the OsteoCare cohort were used to quantify the fracture-
site-specific hospitalisation rate by gender and 5-year age
group.
Thereafter, the remaining lifetime and absolute 10-year
probabilities for osteoporosis-related clinical fractures were
calculated by gender and 5-year age groups by applying the
death risk and incidence tables for Switzerland in 1999
published by the WHO [17]. Finally, BMD and fracture risk
categories, expressed in 0.5 T-score steps at the femoral neck,
taken from a previously published analysis of ten population-
based cohorts [7], were applied to the absolute 10-year and
residual lifetime probability tables. For the following tables,
the T scores shown represent the BMD value at the
1132 Osteoporos Int (2009) 20:1131–1140
beginning of the measurement period, derived from the
NHANES III data for Caucasian women aged 20–29 years
for BMD at the femoral neck [18], including men and as
widely recommended [19].
The calculation flow and the datasets successively used
to determine the residual lifetime and 10-year probabilities
of osteoporosis-related fractures in Switzerland are shown
in Fig. 1. For this analysis, it was assumed that (1) all hip
fractures were hospitalized, which is consistent with the
findings in the Swiss OsteoCare cohort [16]; (2) as all hip
fractures were hospitalised, the same ratio could be used
across age groups for extrapolating the cohort results to
determine the total number of expected osteoporosis-related
fractures as long as it remained gender specific; (3) the
hospitalisation rate for fractures reported in OsteoCare [16]
is the same as for the fractures reported by the SFOS [15];
(4) the BMD distribution is similar to that of US NHANES
III cohort [7, 18]; and (5) the BMD gradient of risk is the
same as reported in the population-based cohorts used for
the FRAX® algorithm [7].
All calculations were made by gender, osteoporosis-related
clinical fracture type and 5-year age groups.
Results
In Switzerland, in year 2000, the selected osteoporosis-related
fracture sites (hip, spine, distal radius and proximal humerus)
represented 63.1% (4,085/6,470) and 75.5% (13,616/18,037)
of all hospitalised clinical osteoporotic fractures in men and
women aged 50 years or older, respectively. The
corresponding fractures in the OsteoCare cohort represented
63.4% (868/1,368) and 71.3% (2,567/3,598) of all registered
fractures in men and women, respectively.
Medical database of the
Swiss Federal Office of Statistics
Hospitalized fractures
Swiss OsteoCare cohort
Hospitalized and 
non-hospitalized fractures
Number of fractures:
Spine (S22.0, 
S22.1, S32.0, 
S32.7, S32.8)
Distal radius
(S52.5, S52.6)
Proximal humerus
(S42.2)
Number of 
fractures: Hip
(S72.0, S72.1, 
S72.2)
Number of fractures:
Spine (thoracic, 
lumbar)
Distal radius
Proximal humerus
Number of 
fractures: Hip
(neck, 
trochanter)
Men: N=2506
Women: N=8074
Men: N=295
Women: N=881
Gender-specific extrapolation ratio
Men: 8.49
Women: 9.16
Expected total number of fractures
(hospitalized and non-hospitalized) 
by 5 year age group and gender
Incidence of all osteoporosis-related
fractures
by 5-year age groups and gender
Hospitalization rates
Absolute 10-year and remaining
lifetime probabilities of osteoporosis-
related fractures by gender, 5-year 
age group and 0.5 SD T-score
categories
WHO death risk and incidence
tables for Switzerland
BMD associated fracture risk
based on 10 population-based
cohorts* and NHANES III**
* Validated by the Swiss SEMOF cohort ** Validated by the reference cohort from Bern
Fig. 1 Analysis flowchart. See
“Methods” section for details
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Calculated incidence of all (hospitalised
and non-hospitalised) osteoporosis-related fractures
The total number of hospitalised and non-hospitalised
osteoporosis-related clinical fractures occurring during
1 year in Switzerland was 8,347 in men and 27,005 in
women corresponding to incidences of 773 and 2,078 per
100,000 persons aged 50 years and older, respectively. In
total, hip fractures represented 30.0% (N=2,506) and
29.9% (N=8,074) of these fractures in men and women,
respectively. Clinical spine, proximal humerus and distal
radius fractures represented 31.4% (N=2,622), 16.6% (N=
1,384) and 22.0% (N=1,835) of these fractures in men and
23.4% (N=6,313), 15.1% (N=4,085) and 31.6% (8,533) in
women, respectively. The detailed incidence rates
corresponding to the year 2000 structure of the resident
population in Switzerland by age group, gender and
fracture site are shown in Table 1.
Hospitalisation rates
Except for hip fractures, where the hospitalisation rate was
assumed to be 100%, fractures of the proximal humerus
were hospitalised in almost 50% of men and more than
50% of women. Approximately one third of all distal
radius fractures and one fourth of all clinical spine
fractures were hospitalised in both men and women. The
hospitalisation rates were generally higher in the younger
(50–59 years) and older (85+) age segments as shown in
Table 2.
Remaining lifetime probability
Overall, the remaining lifetime probability for any osteo-
porosis-related fracture in Switzerland was 20.2% and
51.3% for a 50-year old man and woman, respectively
(Table 3). Remaining lifetime probability of any major
osteoporosis-related fracture increased with advancing age
and with decreasing BMD T-score values at the femoral
neck and was always higher in women than in men
(Table 4). However, lower T-score values increased remain-
ing lifetime probability far more than increasing age. For
example, in a 50 year-old woman, decreasing femoral neck
T-score values from + 1.0 to −4.0 SD with the normative
database of NHANES III were accompanied by an increase
in remaining lifetime probability for hip fracture from 5.2%
to 70.2% (+65% absolute increase). In comparison, an
increase from age 50 to age 85+ years, at a given T score of
−2.5 SD, was accompanied by an increase from 45.1% to
48.4% (+3.3% absolute increase) in remaining lifetime
probability for hip fracture in women. Similar observations
apply to men and to the remaining lifetime probability for
any osteoporotic fracture.
Absolute 10-year probability of osteoporotic fracture
At any age, the absolute 10-year probability for hip fracture
or any osteoporotic fracture increased with advancing age
and was higher in women than in men as shown in Table 3.
In men, the 10-year fracture probability for hip fracture and
any osteoporotic fracture increased from 0.6% at age 50 to
7.4% at age 85+ and from 4.1% at age 50 to 12.7% at age
85+, respectively. In women, the corresponding increases
were from 0.5% to 20.4% and from 6.1% to 33.0%,
respectively (Table 3). The addition of the third parameter,
femoral neck T-score, allowed for a refined risk categorisation
and for the identification of individual absolute 10-year
fracture probabilities up to 45.1% for hip fracture and 66.9%
for any osteoporotic fracture in women, with corresponding
risk levels up to 26.9% and 38.7% in men (Figs. 2 and 3). As
already observed for the remaining lifetime probability of
fracture, the increase in 10-year fracture probability was
steeper with decreasing BMD than with increasing age in both
genders, albeit less pronounced. In men, 10-year lifetime risk
Table 1 Overall (hospitalised and non-hospitalised) incidence of osteoporosis-related fractures (per 100,000) by age groups
Age (years) Hip Spine Distal radius Proximal humerus Any
Men Women Men Women Men Women Men Women Men Women
50–54 48 32 116 121 138 332 76 78 378 563
55–59 81 70 183 141 152 364 66 126 483 702
60–64 93 111 251 304 137 693 131 207 611 1,315
65–69 162 221 223 243 155 568 123 282 663 1,314
70–74 229 426 314 458 109 776 188 337 841 1,996
75–79 454 874 351 954 208 920 187 514 1,199 3,263
80–84 775 1,876 672 1,537 251 1,323 206 936 1,904 5,672
85+ 1,806 3,644 355 1,292 640 1,009 383 665 3,185 6,611
Overall 50+ 232 621 243 486 170 657 128 314 773 2,078
Based on Swiss fracture data from the SFOS [15] and the Swiss OsteoCare cohort [16]
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progression with age flattened or decreased for the older age
group as a result of increasing competition of other causes of
death.
Discussion
The present analysis reports the incidence, the remaining
lifetime probability and the 10-year absolute probability of
suffering from one of the major osteoporotic fractures in
men and women living in Switzerland.
The reported incidences of any (hospitalised or non-
hospitalised) major osteoporotic fracture (hip, spine, distal
radius and proximal humerus) are higher than previously
thought [20, 21]. With regard to hip fractures alone, Sweden
and the USA (Caucasians) are typically considered as very
high risk; UK and Italy are considered as high-risk countries
[20]. As shown in Fig. 4 and depending on the age group
considered, the incidence of the major osteoporotic fractures
in Switzerland was similar to that of the very high-risk
countries or at least at the high end of the high-risk countries
[21]. In the present study, the global incidence of the selected
osteoporosis-related fractures was calculated by deriving the
percentage of hospitalised fractures from a Swiss cohort of
4,966 consecutive patients, aged 50 years or older, who
presented with a clinical fracture at the emergency ward,
seeking medical care. The hospitalisation rates of the non-hip
fractures were derived by assuming that hip fractures were
always hospitalised, i.e. that they would allow for a
correction of the cohort size by applying a gender-specific
correction factor to the previously published data of
hospitalised fractures. The calculated hospitalisation rates
for the major osteoporotic fractures (Table 2) are lower than
the overall hospitalisation rate after fracture in the OsteoCare
cohort, in which 80.2% of the patients were hospitalised
[16]. However, this percentage most certainly reflects a
selection bias due to the fact that the survey was limited to
patients seeking medical care at a hospital emergency ward.
Therefore, and for the first time, by combining fracture
hospitalisation data and clinical fracture incidence data, the
present analysis provides an estimate of the proportion of
patients treated as out-patients after a clinical spine, distal
radius and proximal humerus fracture and leads to fracture
incidences comparable or higher than those reported for
Sweden [22, 23]. Furthermore, approximately one third of all
osteoporotic fractures occurring in men and one fourth of
those in women were not considered in the present analysis,
which leads to an underestimation of fracture risk. On the
Table 3 Overall remaining lifetime probability (percent) for an osteoporosis-related fracture at age 50 years and absolute 10-year osteoporosis-
related fracture probability (percent) at ages shown
Fracture site Gender Remaining lifetime probability at age 50 (%) 10 year probability of fracture at age x (%)
50 55 60 65 70 75 80 85
Hip Men 7.0 0.6 0.8 1.2 1.7 2.6 4.0 5.7 7.4
Women 22.6 0.5 0.9 1.6 3.0 5.6 10.6 16.8 20.4
Any Men 20.2 4.1 5.1 5.7 6.3 7.7 9.8 12.0 12.7
Women 51.3 6.1 9.3 11.9 14.3 20.7 30.1 35.0 33.0
Based on Swiss fracture data from the SFOS [15], the Swiss OsteoCare cohort [16] and death risk and incidence tables for Switzerland published
by the WHO [17]
Table 2 Hospitalisation rates of osteoporosis-related fractures
Age (years) Hip Spine (%) Distal radius (%) Proximal humerus (%)
Men Women Men Women Men Women Men Women
50–54 100% 43.7 25.6 33.7 20.4 48.7 46.9
55–59 28.4 31.1 36.1 30.5 50.0 42.9
60–64 27.1 14.0 35.8 24.4 31.7 28.5
65–69 28.2 25.2 36.9 38.3 39.3 43.7
70–74 21.2 24.2 28.2 39.4 27.1 57.9
75–79 25.9 21.4 16.9 40.5 50.0 58.7
80–84 18.4 17.9 21.6 33.7 52.7 45.7
85+ 63.4 26.4 9.0 42.7 48.4 76.5
Overall 29.1 22.3 28.2 34.1 41.9 52.6
A 100% hospitalisation rate was assumed for hip fractures. Based on Swiss fracture data from the SFOS [15] and the Swiss OsteoCare cohort [16]
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Table 4 Remaining lifetime probability for an osteoporosis-related fracture (percent) by gender, age and femoral neck T score
Femoral neck T score Probability of hip fracture from x to death (%)
50 55 60 65 70 75 80 85
Hip fracture
Men
−4.0 51.5 51.0 49.9 49.8 49.5 51.2 52.6 55.6
−3.5 41.7 41.3 40.5 40.4 40.2 41.7 43.1 45.8
−3.0 32.6 32.3 31.7 31.6 31.5 32.8 34.0 36.3
−2.5 24.7 24.4 23.9 23.9 23.9 24.9 25.9 27.7
−2.0 18.1 18.0 17.6 17.6 17.6 18.4 19.1 20.5
−1.5 13.0 12.9 12.6 12.6 12.7 13.2 13.8 14.8
−1.0 9.2 9.1 8.9 8.9 8.9 9.3 9.7 10.5
−0.5 6.4 6.3 6.2 6.2 6.2 6.5 6.8 7.3
0.0 4.4 4.4 4.3 4.3 4.3 4.5 4.7 5.0
0.5 3.0 3.0 2.9 2.9 2.9 3.1 3.2 3.4
1.0 2.0 2.0 2.0 2.0 2.0 2.1 2.2 2.3
Women
−4.0 70.2 70.7 71.1 71.9 73.1 74.7 76.6 76.5
−3.5 62.8 63.2 63.7 64.5 65.6 67.2 68.9 68.6
−3.0 54.3 54.7 55.1 55.8 56.8 58.2 59.7 58.9
−2.5 45.1 45.4 45.7 46.4 47.2 48.4 49.5 48.4
−2.0 36.0 36.2 36.5 37.0 37.6 38.5 39.3 38.1
−1.5 27.6 27.8 28.0 28.4 28.9 29.5 30.0 28.9
−1.0 20.5 20.7 20.8 21.1 21.4 21.9 22.3 21.3
−0.5 14.9 15.0 15.1 15.3 15.5 15.9 16.1 15.3
0.0 10.6 10.7 10.7 10.9 11.1 11.3 11.4 10.8
0.5 7.4 7.5 7.5 7.6 7.8 7.9 8.0 7.6
1.0 5.2 5.2 5.2 5.3 5.4 5.5 5.6 5.3
Any osteoporotic fracture
Men
−4.0 59.1 58.0 56.1 54.9 53.9 54.8 55.7 57.8
−3.5 51.1 50.0 48.2 46.9 45.8 46.5 47.3 48.9
−3.0 43.7 42.5 40.8 39.3 38.3 38.6 39.2 40.2
−2.5 37.0 35.8 34.2 32.6 31.6 31.6 31.9 32.4
−2.0 31.3 30.1 28.6 27.0 25.9 25.6 25.7 25.7
−1.5 26.6 25.5 24.0 22.4 21.3 20.9 20.7 20.3
−1.0 22.9 21.8 20.4 18.8 17.7 17.1 16.8 16.1
−0.5 20.0 18.9 17.6 16.0 15.0 14.3 13.8 12.9
0.0 17.6 16.6 15.3 13.9 12.8 12.1 11.6 10.6
0.5 15.8 14.8 13.6 12.2 11.2 10.4 9.9 8.8
1.0 14.3 13.4 12.2 10.9 9.9 9.2 8.6 7.5
Women
−4.0 79.3 79.1 79.0 78.5 78.9 79.7 80.6 78.8
−3.5 75.1 74.8 74.6 73.9 74.1 74.7 75.2 72.5
−3.0 70.4 70.0 69.7 68.7 68.7 68.9 68.8 65.0
−2.5 65.4 64.9 64.4 63.1 62.9 62.6 61.9 56.9
−2.0 60.3 59.6 59.0 57.5 56.9 56.3 54.9 48.9
−1.5 55.3 54.6 53.9 52.1 51.3 50.3 48.2 41.6
−1.0 50.8 50.0 49.1 47.2 46.2 44.9 42.4 35.3
−0.5 46.7 45.9 45.0 42.9 41.7 40.2 37.4 30.1
0.0 43.2 42.3 41.4 39.2 38.0 36.3 33.3 26.0
0.5 40.1 39.2 38.3 36.1 34.8 33.0 30.0 22.7
1.0 37.5 36.6 35.6 33.4 32.1 30.3 27.2 20.2
Based on Swiss fracture data from the SFOS [15], the Swiss OsteoCare cohort [16], death risk and incidence tables for Switzerland published by
the WHO [17], BMD gradients of risk determined in ten international population-based cohorts [7] validated for Switzerland [12] and BMD
normative data from US NHANES III [18]
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other hand, the cohorts used did not allow for a differenti-
ation between first and subsequent fractures. As a prior
history of fragility fracture increases the risk for subsequent
fractures [12, 20, 24], this might have led to an overestima-
tion of the individual fracture risk based on the three
characteristics of gender, age and BMD only.
Switzerland belongs to the countries with the highest life
expectancy at birth worldwide (76.7 years for men and
82.5 years for women in 2001) [25] and a stronger increase
in the number of nonagenarians and centenarians than in
other countries was recently reported, mostly attributable to
the decline in mortality after the age of 80 years, which had
started already in the 1950s [26]. For this reason, Switzer-
land ranks second worldwide after Japan with regard to the
number of elderly in the resident population [26]. Further-
more, the recent demographic scenarios projecting the
aging of the population in Switzerland between 2005 and
2050 [27] showed that this increasing trend will not level-
off before year 2050, leading to almost a doubling of the
population older than 65 years of age by that date (Fig. 5).
Based on current trends and on age distribution alone,
Switzerland can therefore be expected to become the
European country exposed earliest to the massive impact
of the societal and economic consequences of an increasing
number of osteoporotic fractures and may be considered as
a paradigm for the unfortunate future of most other
European countries.
Based on the present results, in Switzerland, one out of
five 50-year-old men and one out of two 50-year-old
women will suffer from at least one clinical fracture of the
hip, the spine, the distal radius and/or the proximal humerus
during their remaining lifetime. These figures are consistent
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with the estimated long-term risk for any of these
osteoporotic fractures in Malmö, Sweden of 23.8% and
47.3% in 45-year-old men and women, respectively [23].
They are also consistent with earlier findings from the
population-based Study of Osteoporotic Fractures in the
USA, according to which a 50-year-old white woman had a
16% risk of suffering a hip fracture, a 15% risk of suffering
a radius fracture and a 32% risk of sustaining a vertebral
fracture during her remaining lifetime [28] and with recent
results from the Australian Dubbo study, which showed a
remaining lifetime probability for any low-trauma non-
pathological fracture at age 60 of 25% in men and 44% in
women, respectively, after adjustment for competing risk of
death [29]. These remaining lifetime probabilities can also
be compared to other diseases such as atherosclerotic
cardiovascular disease (myocardial infarction, coronary
insufficiency, angina, stroke and claudication) with a
lifetime risk at age 50 years of 51.7% for men and 39.2%
for women [30]; clinical stroke, lifetime risk at age 65 years
of 14.5% for men and 16.1% for women [31]; congestive
heart failure, lifetime risk at age 40 years of 21.0% for men
and 20.3% for women [32]; and cancer, lifetime risk at birth
of being diagnosed with any cancer of 44.9% in men and
37.5% in women [33].
The concept of absolute fracture risk accommodates for
the background prevalence of a disease, a clinically relevant
dimension, which is lost when using relative risks. In other
words, for two distinct diseases with identical relative risks,
the absolute risk will be higher for the disease with the
highest prevalence. Furthermore, absolute fracture risk
reporting is preferred to the traditional T-score reporting
by Canadian physicians, non-specialist physicians being
particularly supportive of risk-based BMD reporting [34], and
is being increasingly adopted in clinical guidelines [35–39]
and for the development of new drugs [40]. It is therefore
reasonable to assume that an absolute fracture risk, i.e. the
probability of sustaining a fracture during a given timeframe,
will not only be more appealing to physicians but also more
accessible to patients than the abstract T-score value of a DXA
measurement. Ten-year absolute fracture probability data by
gender, age and femoral neck T-score categories are herewith
available for Switzerland. A recently published analysis of
nine prospective population-based epidemiological studies
from the USA, Europe, Australia and Asia, comprising
46,340 men and women followed for approximately
190,000 person-years in which 4,168 osteoporotic fractures
were reported, allowed the identification of the following
additional clinical risk factors for fractures: BMI, prior
fragility fracture, parental history of hip fracture, current
tobacco smoking, ever long-term use of glucocorticoids,
rheumatoid arthritis, other causes of secondary osteoporosis
and alcohol consumption of three or more units daily [12].
These data, which are generally usable throughout the world
combined with the present results and which are specific for
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Switzerland and other high-risk countries, will allow for the
development of a fracture risk assessment tool (FRAX®), as it
has already been published for the UK, the US and Japan [4,
11, 14] with the aim of identifying those patients in the low
BMD range (T-score −1 to −2.5 SD) who have the highest
risk of fracture and would potentially benefit from treatment.
Even if BMD alone were shown to outperform the clinical
risk factors for predicting fracture risk at all ages [12], a
significant percentage of the osteoporotic fractures occur in
patients who do not meet the WHO T-score threshold of −2.5
SD required by the authorities in many countries for
reimbursement of drug therapy aiming at preventing the first
or subsequent fracture [16, 41]. The present data, and even
more so, once interpolated with all identified clinical risk
factors for FRAX®, will contribute to improving the
predictive value of BMD measurements for fracture risk
prediction [12].
One strength of the present analysis is its internal
consistency with the use of Swiss national epidemiological
data, whenever possible. Several assumptions (see “Methods”)
were required to ensure the present validation process of
FRAX® for Switzerland. It was assumed that BMD distribu-
tion at the femoral neck in Switzerland will be similar to that
in the US NHANES III cohort [7, 18]. This assumption can
be considered as robust. In a representative population of 400
Caucasian women and men, 20–80 years of age living in the
area of Berne, the distribution of the BMD values at the
femoral neck was compared to that of NHANES III (data not
shown). This population had already served as the reference
population in clinical trials published earlier [42]. Further-
more, it was assumed that the BMD gradient of risk will be
the same as reported in the population-based cohorts used for
the FRAX® algorithm [7]. For the latter, the Swiss SEMOF
cohort [43] was used as a validation cohort [12], which
reinforces the validity of the assumption. However, in the
present study, the interpolation with the BMD T-score
categories relied on the published NHANES III data at the
femoral neck only. Whether the same conclusions would
apply by using BMD values measured by DXA at other sites,
established by using other BMD measurement devices than
DXA, such as ultrasound or peripheral QCT, and/or by using
a normative database for femoral neck T scores other than
NHANES III, cannot be answered by this study.
In conclusion, the present study validated the elements
required for the development of a FRAX® model for use in
Switzerland. It shows that Switzerland belongs to the high
end of the spectrum of risk for osteoporotic fractures and
that the burden of disease is comparable to that of
cardiovascular diseases and cancer. The future determina-
tion of the individual fracture risk based on a more
encompassing clinical risk factor profile will aid in
identifying those patients who will benefit most from
fracture prevention measures.
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